784966008: Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing beta adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing beta adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing beta adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic neurone blocker (product)\Product containing guanethidine (medicinal product)\Product containing guanethidine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic neurone blocker (product)\Product containing guanethidine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing adrenergic neurone blocker (product)\Product containing guanethidine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing adrenal hormone (product)\Adrenal medulla hormone-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing adrenal hormone (product)\Adrenal medulla hormone-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing adrenal hormone (product)\Adrenal medulla hormone-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\Product containing epinephrine (medicinal product)\...

\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Product manufactured as ocular dose form (product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product manufactured as ocular dose form (product)\Product containing guanethidine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

\Product containing autonomic agent (product)\Product containing adrenergic neurone blocker (product)\Product containing guanethidine (medicinal product)\Product containing guanethidine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing adrenergic neurone blocker (product)\Product containing guanethidine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing adrenergic neurone blocker (product)\Product containing guanethidine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing beta adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing beta adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing beta adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine in ocular dose form (medicinal product form)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline and guanethidine only product\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution
\Product containing autonomic agent (product)\Product containing sympathomimetic (product)\Product containing adrenergic receptor agonist (product)\Product containing alpha adrenergic receptor agonist (product)\Alpha-adrenergic and beta-adrenergic agonist-containing product\Product containing epinephrine (medicinal product)\Product containing epinephrine and guanethidine (medicinal product)\Adrenaline- and guanethidine-containing product in ocular dose form\Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)\Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3765863011 Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3765864017 Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3765865016 Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Plays role	Antiglaucoma therapeutic role	false	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has manufactured dose form	Conventional release eye solution (dose form)	true	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Count of base of active ingredient	deux	false	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	This attribute specifies the denominator unit for the concentration strength of a product.	mL	true	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator value	un	false	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Is a	Product containing only epinephrine and guanethidine in ocular dose form (medicinal product form)	true	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength denominator value	un	false	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator value	2.5	false	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Epinephrine bitartrate (substance)	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Epinephrine (substance)	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	Has concentration strength numerator value	500	false	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Guanethidine (substance)	true	Inferred relationship	Some	2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	This attribute specifies the numerator unit for the concentration strength of a product.	mcg	true	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Guanethidine (substance)	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3765863011	Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3765864017	Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3765865016	Epinephrine (as epinephrine bitartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core